Artificial Cells Nanomedicine and Biotechnology · 2018 · 33 citations · 22 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryOral Drug DeliveryCancer Drug DeliveryDrug EncapsulationNanomedicineNanoparticle Delivery SystemsOral NanocarriersSelf-emulsifying Drug Delivery SystemsBox-behnken DesignsControlled Drug ReleaseDrug Delivery NanocarriersEntrapmentOral Drug Delivery FormulationsOral Drug Delivery SystemsOral Nanoparticle BioavailabilitySelf-nanoemulsifying Drug Delivery Systems
M cell cycle arrest, apoptosis, mitochondrial membrane potential disruption and ROS production was exhibited by PTX-SEDDS in comparison to Taxol. Up-regulation of Bax, p21, cleaved-caspase 3, -caspase 9 and down-regulation of Bcl2 and survivin suggested apoptosis via intrinsic pathways. Pharmacokinetic study showed approximately 4-folds higher oral bioavailability of PTX-SEDDS than Taxol. Significant reduction in tumour volume and weight was observed in syngeneic mammary tumour in SD rats. Tumour histopathology and TUNEL assay showed apoptosis in tumour tissue. PTX-SEDDS caused low lung metastasis, and was safe and stable. Conclusively, PTX-SEDDS could be suitable option for oral delivery of PTX.
22
D. W. Smithers · The Lancet · 1956 · 1.8K citations
How Taxol/paclitaxel kills cancer cells
Beth A. Weaver · Molecular Biology of the Cell · 2014 · 1.6K citations
Medicine, Oncology, Pharmacology +13